Peristeen Light - trans anal irrigation system
DeviceSubjects naive to TAI will use Peristeen Light trans anal irrigation
NCT Number: NCT07126327
The goal of this exploratory clinical investigation is to understand the clinical benefits of Peristeen Light in adult patients with faecal incontinence, chronic constipation and/or time-consuming bowel management procedures.
The primary objective is to evaluate changes in bowel-function when using Peristeen Light. Participants will use Peristeen Light for 12 weeks test period.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Århus University Hospital, Aarhus, Gotland, Denmark
The goal of this exploratory clinical investigation is to understand the clinical benefits of Peristeen Light in adult patients with faecal incontinence, chronic constipation and/or time-consuming bowel management procedures.
The primary endpoint is bowel function measured on a 10 cm Visual Analog Scale (VAS) at Baseline Visit and end of Clinical Investigation visit.
Participants will use Peristeen Light for 12 weeks test period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects naive to TAI will use Peristeen Light trans anal irrigation
Time frame: From enrollment to the end of treatment at week 12.
0 cm = worst possible bowel function and 10 cm = best possible bowel function.
Contact information is provided by the study sponsor or research team.
Coloplast A/S
Industry
An Explorative Clinical Investigation to Understand the Clinical Benefits of Peristeen Light
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03078634
Behavior, Behavioral Symptoms
Melbourne, Victoria, Australia
View Trial DetailsNCT07573371
Behavior, Behavioral Symptoms
Aalborg, Denmark
View Trial DetailsNCT04918329
Abdominal Pain, Abdominal Pain (AP)
Rouen, France
View Trial DetailsNCT05550675
Behavior, Behavioral Symptoms
Brussels, Brussels Capital, Belgium
View Trial Details